NASDAQ · Medical - Pharmaceuticals

PETS (PETS) Stock

$1.95 -1.52% NASDAQ: PETS Healthcare

Valuation

MetricValue
Price$1.95
Market Cap$41.68M
P/E Ratio-7.43
P/B Ratio0.56
P/S Ratio0.26
EPS (TTM)$-0.30
52-Week High$4.10
52-Week Low$1.57
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-7.06%
ROA-4.03%
ROCE-2.35%
Gross Margin-0.88%
Operating Margin-0.88%
Net Margin-35.51%
Debt/Equity0.02
Current Ratio1.25

Annual Financials (USD)

Metric20212022202320242025
Revenue$304.0M$273.0M$257.0M$274.0M$227.0M
Operating Profit$31.0M$26.0M$7.0M$-7.0M$-2.0M
Net Profit$24.0M$21.0M$5.0M$-7.0M$-6.0M
EPS$1.52$1.04$0.25$-0.37$-0.30
Op Margin10.1%9.4%2.5%-2.5%-0.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$187.0M$176.0M$170.0M$170.0M$149.0M
Total Liabilities$46.0M$34.0M$60.0M$73.0M$64.0M
Cash$119.0M$111.0M$104.0M$55.0M$55.0M
Borrowings$0$0$1.0M$1.0M$1.0M

Latest News

PetMeds and Rural King Expand Access to Pet Healthcare Through New Online Pharmacy Platform GlobeNewswire · Jul 14, 2026 Sector Update: Healthcare Stocks Decline Tuesday Afternoon MT Newswires · Jun 30, 2026 PetMed Express Receives Unsolicited Acquisition Proposal From SilverCape Investments MT Newswires · Jun 30, 2026 PetMed Express, Inc. Confirms Receipt of Unsolicited, Non-Binding, and Conditional Acquisition Proposal from SilverCape Investments Limited GlobeNewswire · Jun 30, 2026 SilverCape Releases Revised Proposal to Acquire PetMed Express for $3.00 per Share in Cash GlobeNewswire · Jun 29, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$40.0M$18.0M$28.0M$4.0M$5.0M
Investing Cash Flow$-5.0M$-4.0M$-16.0M$-45.0M$-10.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$15.0M$-8.0M$-7.0M$-49.0M$-1.0M
Free Cash Flow$38.0M$17.0M$23.0M$0$0

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA-1.26
FCF Yield-48.03%
Quick Ratio0.66
Interest Coverage—
Return 1Y-35.66%
Return 3Y-84.99%
Return 5Y-92.05%

Ownership

Insiders Held15.57%
Institutions Held44.54%
Institutions Float Held52.75%
Institutional HolderSharesReport Date
Renaissance Technologies, LLC1,186,3692026-03-31
Vanguard Capital Management LLC831,4312026-03-31
Federated Hermes, Inc.666,8052026-03-31
Blackrock Inc.551,6772026-03-31
Hotchkis & Wiley Capital Management, LLC514,5432026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BDSX $20.38 -3.09% -2.82 $165.90M 0.00%
CTSO $0.35 -4.32% -3.62 $22.25M 0.00%
FBIO $2.67 -3.61% 0.91 $88.69M 0.00%
GNTAGenenta Science S.p.A. $1.50 -5.66% -3.98 $28.72M 0.00%
ICCM $2.88 +3.23% -1.00 $6.49M 0.00%

About PETS

PETS is led by CEO Leslie C. G. Campbell, employs 287 people, headquartered in US, publicly traded since 1999.

PETS stock trades at $1.95 with a market capitalization of $41.68M. The stock is valued at a price-to-earnings (P/E) ratio of -7.43, price-to-book of 0.56, price-to-sales of 0.26. Over the past 52 weeks the stock has ranged between $1.57 and $4.10, and currently trades 52.4% below its 52-week high.

On profitability, PETS generates a return on equity (ROE) of -7.06%, return on capital employed of -2.35%, an operating margin of -0.88%, a net profit margin of -35.51%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides